196 related articles for article (PubMed ID: 1080869)
1. [Mucous membrane specific protease inhibitors in bronchial mucus in severe chronic obstructive bronchitis and in alpha 1-antitrypsin deficiency syndrome].
Rasche B; Hochstrasser K; Marcic I; Ulmer WT
Respiration; 1975; 32(5):340-54. PubMed ID: 1080869
[TBL] [Abstract][Full Text] [Related]
2. [Inhibitors of proteases in bronchial secretion of patients deficient in alpha-l-antitrypsin].
Laine A; Lebas J; Hayem A
Lille Med; 1976 Feb; 21(2):140-3. PubMed ID: 1084948
[No Abstract] [Full Text] [Related]
3. [Concentration of low-molecular protease inhibitor in the bronchial secretion in 1 -antitrypsin deficiency].
Reichert R; Hochstrasser K; Fruhmann G; Fritz H; Werle E
Pneumonologie; 1972; 147(1):41-5. PubMed ID: 5083260
[No Abstract] [Full Text] [Related]
4. [The role of granulocytic proteinases and their inhibitors in the pathogenesis of nonspecific endobronchitis (review)].
Ogloblina OG
Vopr Med Khim; 1984; 30(1):3-13. PubMed ID: 6324487
[TBL] [Abstract][Full Text] [Related]
5. Effect of corticosteroids on sputum sol-phase protease inhibitors in chronic obstructive pulmonary disease.
Wiggins J; Elliott JA; Stevenson RD; Stockley RA
Thorax; 1982 Sep; 37(9):652-6. PubMed ID: 6984237
[TBL] [Abstract][Full Text] [Related]
6. Protease inhibitors in patients with chronic obstructive pulmonary disease: the alpha-antitrypsin heterozygote controversy.
Cox DW; Hoeppner VH; Levison H
Am Rev Respir Dis; 1976 May; 113(5):601-6. PubMed ID: 1083700
[TBL] [Abstract][Full Text] [Related]
7. Elastase inhibitors of sputum sol phase: variability, relationship to neutrophil elastase inhibition, and effect of corticosteroid treatment.
Stockley RA; Morrison HM; Kramps JA; Dijkman JH; Burnett D
Thorax; 1986 Jun; 41(6):442-7. PubMed ID: 2431494
[TBL] [Abstract][Full Text] [Related]
8. [The protease-inhibitor capacity of human bronchial mucus. Content in low molecular inhibitor and 1 -antitrypsin under physiological and physiopathological conditions].
Reichert R; Hochstrasser K; Conradi G
Pneumonologie; 1972; 147(1):13-20. PubMed ID: 5083256
[No Abstract] [Full Text] [Related]
9. Alpha 1-antichymotrypsin in infected and noninfected sputum.
Stockley RA; Burnett D
Am Rev Respir Dis; 1980 Jul; 122(1):81-8. PubMed ID: 6893262
[TBL] [Abstract][Full Text] [Related]
10. Elastase inhibitors in sputum from bronchitic patients with and without alpha 1-proteinase inhibitor deficiency: partial characterization of a hitherto unquantified inhibitor of neutrophil elastase.
Morrison HM; Kramps JA; Afford SC; Burnett D; Dijkman JH; Stockley RA
Clin Sci (Lond); 1987 Jul; 73(1):19-28. PubMed ID: 2440636
[TBL] [Abstract][Full Text] [Related]
11. Protease inhibitors in chronic obstructive pulmonary disease.
Barnett TB; Gottovi D; Johnson AM
Am Rev Respir Dis; 1975 May; 111(5):587-93. PubMed ID: 1079422
[TBL] [Abstract][Full Text] [Related]
12. Low molecular mass bronchial proteinase inhibitor and alpha 1-proteinase inhibitor in sputum and bronchoalveolar lavage.
Stockley RA; Morrison HM; Smith S; Tetley T
Hoppe Seylers Z Physiol Chem; 1984 May; 365(5):587-95. PubMed ID: 6332053
[TBL] [Abstract][Full Text] [Related]
13. Proteinase inhibitors in rheumatoid arthritis.
Brackertz D; Hagmann J; Kueppers F
Ann Rheum Dis; 1975 Jun; 34(3):225-30. PubMed ID: 1080403
[TBL] [Abstract][Full Text] [Related]
14. Variability in sputum sol phase proteins in chronic obstructive bronchitis. The value of using albumin for standardization.
Wiggins J; Stockley RA
Am Rev Respir Dis; 1983 Jul; 128(1):60-4. PubMed ID: 6603183
[TBL] [Abstract][Full Text] [Related]
15. The biochemical pathogenesis of chronic obstructive pulmonary diseases: protease-antiprotease imbalance in emphysema and diseases of the airways.
Kuhn C
J Thorac Imaging; 1986 Mar; 1(2):1-6. PubMed ID: 3298671
[TBL] [Abstract][Full Text] [Related]
16. Airways inflammation in chronic bronchitis: the effects of smoking and alpha1-antitrypsin deficiency.
Hill AT; Bayley DL; Campbell EJ; Hill SL; Stockley RA
Eur Respir J; 2000 May; 15(5):886-90. PubMed ID: 10853853
[TBL] [Abstract][Full Text] [Related]
17. The mucosal defence capacity against proteolytic leukocyte enzymes.
Tegner H; Fryksmark U; Ohlsson K
Eur J Respir Dis Suppl; 1985; 139():62-5. PubMed ID: 3876236
[TBL] [Abstract][Full Text] [Related]
18. [Proteolytic and antitrypsin activity of plasma in patients with bronchial asthma and chronic bronchitis with coexisting emphysema].
Hofman J; Matusiewicz R
Pol Arch Med Wewn; 1973 Apr; 50(4):345-52. PubMed ID: 4702958
[No Abstract] [Full Text] [Related]
19. SPARTA clinical trial design: exploring the efficacy and safety of two dose regimens of alpha1-proteinase inhibitor augmentation therapy in alpha1-antitrypsin deficiency.
Sorrells S; Camprubi S; Griffin R; Chen J; Ayguasanosa J
Respir Med; 2015 Apr; 109(4):490-9. PubMed ID: 25727857
[TBL] [Abstract][Full Text] [Related]
20. [Changes in protease inhibitor balance of the bronchoalveolar secretion in children with inflammatory lung diseases].
Bogadel'nikov IV; Kubyshkin AV; Gavalova NG
Pediatriia; 1990; (3):17-20. PubMed ID: 2385464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
